Watch this complimentary webcast in which PMCF Manager from Purdie Pascoe, Chris Webb, presented with Dr. Ulrich Nitsche Global Director Clinical Centre of Excellence from TÜV SÜD and Dr. Nikhil A. Khadabadi from Eclevar MedTech. These leading experts unpack critical PMCF strategies, share real-world survey experiences, and offer insights on bridging data gaps to achieve regulatory success.

In the second blog of our PMCF Insights Series, Tonika Chester and Isabel Bradshaw explore off-label usage within medical devices, from collecting off-label data in post market clinical follow up, understanding and key considerations for off-label usages to the challenges in paediatric populations and rare diseases.

Purdie Pascoe is conducting an ongoing ctDNA Cancer Monitoring US Landscape syndicated study. The first two waves are available for purchase, with a third wave set to launch soon.

A leading medical device manufacturer required Post Market Clinical Follow-Up (PMCF) data for their Class III Peripherally Inserted Central Catheter (PICC). This clinical evidence was needed to comply with PMCF data collection under the MDR

Marianne Fillion provides insights about the Precision Medicine and Diagnostics market research function at Purdie Pascoe. She delves into technological advancements, the competitive oncology landscape and why market research is so important for development and implementation in this space.

In 2024, Stephen Potts, Director at Purdie Pascoe, was diagnosed with a giant brain aneurysm that required complex surgery and a long recovery journey. Thanks to the exceptional care from his surgeons, doctors, therapists and nurses, Stephen has made significant strides in his recovery and is now enthusiastically back at work.

We are thrilled to announce that Marcus Torr, PMCF/MDR Lead at Purdie Pascoe, has been selected for the MedTech Leading Voice (MLV) list for 2025. Marcus regularly shares his expertise at industry events and on LinkedIn. We are incredibly proud to see him featured in the prestigious MLV100 list. Don't miss his future insights by following him on LinkedIn.

At Purdie Pascoe, one of our core values is ‘Supportive.’ We are dedicated to helping local communities and charities, doing our part to assist those in need. Our charity initiative group works tirelessly throughout the year to identify the best ways to support a variety of charities and local communities.

We are delighted to be exhibiting and presenting a paper at the Pharma Market Research Conference (PMRC) from February 5-6 in New Jersey. Sabera Hyderally, Head of MedTech and Kristy Beede, Director, will be representing Purdie Pascoe at the event.

Find out how we provided our client with a clear and effective path forward to help launch their pre-filled syringes for subcutaneous immunoglobulin therapy, and how best to position themselves for widespread adoption.

In the first blog of our PMCF Insights Series, Hemant Mistry and Matthew Hanson explore different types of bias in medical device research, the measures being taken to address these issues, and how Purdie Pascoe's deep expertise helps eliminate bias in PMCF surveys.

Lindsey Cotterill provides her perspective about the importance of a robust operations and compliance function to ensure seamless execution of primary market research projects and PMCF surveys. She delves into key compliance regulations, strategies to ensure security and confidentiality of data and how each Purdie Pascoe employee is diligently trained about compliance issues and best practices.

We are thrilled to announce that Hazel Haskayne has joined Purdie Pascoe’s UK-based primary market research division as Director. With over 25 years of experience in healthcare market research, Hazel has led strategic, consultative projects for clients across the globe.

A leading medical device manufacturer required Post Market Clinical Follow-Up (PMCF) data for their legacy Class I syringe. This clinical evidence was needed to comply with PMCF data collection under the EU-MDR. Find out how our PMRC survey approach strengthened the regulatory compliance for their device.

2024 has been a great year for Purdie Pascoe, from opening our US office, becoming a BCorp, expanding our service offerings to growing our talented team. To round off the year, our global team delivers our very own festive poem: 'Twas the Night Before Christmas at Purdie Pascoe'…

Marcus Torr provides about his perspective about the importance of PMCF Survey implementation for medical device EU-MDR submissions. He reveals why medical device manufacturers should consider PMCF surveys, how to overcome challenges, solutions for a best practice approach and what makes Purdie Pascoe’s specialist expertise unique.

Purdie Pascoe is delighted to announce the findings from the second wave of our syndicated ctDNA Cancer Monitoring study have been published and are available to purchase. If you are interested in purchasing both waves, our consultants would be delighted to discuss a special pricing agreement. 

Earlier this year Freya Lovely, Senior Research Executive at Purdie Pascoe, won the EPHMRA Young Professionals Award. In this piece, she provides key insights regarding the benefits of winning the award, being a member of the Young Professionals Committee and attending the June conference.

In this episode Podymos interviewed Purdie Pascoe MedTech experts Sabera Hyderally and Guy Pascoe, who takes us on a journey through the product lifecycle and how market research can significantly increase market adoption, and boost your marketing strategy.

Purdie Pascoe Post Market Clinical Follow-up (PMCF) Survey experts, Marcus Torr and Chris Webb recently attended the RAPS European Clinical, Risk and Postmarket Surveillance Conference in Barcelona, Spain.